Clinical trial
Effect of Inhibition Soluble Epoxide Hydrolase on Insulin Sensitivity in Humans
NCT03486223 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Inhibition Soluble Epoxide Hydrolase on Insulin Sensitivity in Humans
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 17, 2018
- Completion date
- November 18, 2021
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.